News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yelena Janjigian: Amgen Reports Positive Phase 3 Results for Bemarituzumab in FGFR2b+ Gastric Cancer
Yelena Janjigian/LinkedIn
Jul 1, 2025, 05:33

Yelena Janjigian: Amgen Reports Positive Phase 3 Results for Bemarituzumab in FGFR2b+ Gastric Cancer

Yelena Janjigian, Chief of Gastrointestinal Oncology at Memorial Sloan Kettering Cancer Center, posted on LinkedIn:

“FGFR2B expression as a bookmaker in first line GEC.
Congratulations to all the investigators.”

Read Further.

Read Further: Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology.

Amgen cancer GI cancer OncoDaily Oncology Yelena Janjigian
Special Coverage
Voices
Aug 10, 2025, 04:25
What is Radioligand Therapy for Lung Cancer? - Lung Cancer Europe
Societies
Aug 10, 2025, 02:08
10 Must-Read Posts in Immuno-Oncology This Week
Voices
Aug 9, 2025, 22:35
Naoto T. Ueno: No Difference in pCR, but Better Disease Control With Anthracyclines in HER2+ IBC
Voices
Aug 9, 2025, 22:17
Chadi Nabhan: How We Approach Papillary Renal Cell Cancer in Less Than 10 Minutes
Voices
Aug 9, 2025, 21:55
Andrea Necchi: Exploratory Biomarker Analyses of Adjuvant Nivolumab in Urothelial Carcinoma
Career
Aug 9, 2025, 21:22
Tomás Dalotto-Moreno Awarded 2025 MONARCA Grant for Latin America - AACR
Voices
Aug 9, 2025, 21:21
Bishal Gyawali: This Has Always Been Our Bottom Line
Insight
Aug 9, 2025, 21:07
Sakditad Saowapa: The Importance of Early detection in Pancreatic Cancer
Voices
Aug 9, 2025, 20:51
Vivek Subbiah: It Takes a Village to Bring Cutting-Edge Care to All Patients
Insight
Aug 9, 2025, 20:05
ImmunoHistoFluorescence Method for Sub-Nuclear Protein Analysis in Tissue - Danish Cancer Institute
Voices
Aug 9, 2025, 19:54
Wee Joo Chng: Another Very Successful Asian Myeloma Network Masterclass
Voices
Aug 9, 2025, 19:53
Margaret Locke: Our Work on Expediting Molecular Testing for New NSCLC